Clinipace names global medical affairs VP
This article was originally published in Scrip
Morrisville, North Carolina-based Clinipace, a digital contract research organization (dCRO), has named Dr Roger Morgan executive vice-president of global medical affairs. Dr Morgan, a trained surgeon, joins the dCRO from Kowa Research Institute where he was chief medical officer. At Clinipace Dr Morgan will provide oversight and leadership for the global medical affairs department, including the cardiometabolic team, medical monitoring, and the pharmacovigilance/safety groups.
You may also be interested in...
Funded by the UK government, The Rosalind Franklin Institute works with industrial and academic partners from across the UK to foster interdisciplinary research with “real impact.” Leaders from the growing institute talk to In Vivo about validating its success and what it means to seek truly ground-breaking innovation in 2021.
In Vivo's Deal-Making column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in June 2021. Data provided by Biomedtracker.
Sublicensing rights, revenue considerations, licensed know-how and diligence milestones: getting these elements right in deals with academic institutions sets the tone for biotechs as they grow and seek partnering opportunities with big pharma.